A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity

Molecular Therapy
April 20, 2022
Cited by 56


Related Papers

No related papers found

Powered by citation graph analysis